December 2024's Leading Growth Stocks With High Insider Ownership

As the global markets navigate a landscape marked by political upheavals in Europe and mixed economic signals, U.S. major indexes have shown resilience, with growth stocks leading the charge amid record highs for the S&P 500, Dow Jones Industrial Average, and Nasdaq Composite. In this environment of sectoral divergence and economic anticipation ahead of key central bank meetings, identifying growth companies with high insider ownership can offer insights into market leaders that are well-aligned with internal stakeholder interests.

Top 10 Growth Companies With High Insider Ownership
Name Insider Ownership Earnings Growth
People & Technology (KOSDAQ:A137400) 16.4% 37.3%
SKS Technologies Group (ASX:SKS) 27% 24.8%
On Holding (NYSE:ONON) 19.1% 29.4%
Medley (TSE:4480) 34% 31.7%
Pharma Mar (BME:PHM) 11.8% 56.2%
Plenti Group (ASX:PLT) 12.8% 120.1%
Brightstar Resources (ASX:BTR) 16.2% 84.5%
Credo Technology Group Holding (NasdaqGS:CRDO) 13.5% 65.9%
Elliptic Laboratories (OB:ELABS) 26.8% 111.4%
Findi (ASX:FND) 34.8% 112.9%

Click here to see the full list of 1515 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

Advanced Nano Products (KOSDAQ:A121600)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Advanced Nano Products Co., Ltd. manufactures and sells high-tech materials, including displays, semiconductors, secondary batteries, and solar cells in South Korea and internationally, with a market cap of approximately ₩793.25 billion.
Operations: The company's revenue primarily comes from its Specialty Chemicals segment, amounting to approximately ₩86.63 billion.
Insider Ownership: 22.6%
Advanced Nano Products is poised for significant growth, with earnings expected to rise 70% annually, outpacing the KR market's 29.6%. Revenue growth is also projected at 45% per year. Despite this potential, recent financials reveal challenges: third-quarter net income dropped to KRW 488.02 million from KRW 4,398.15 million a year ago. The stock trades slightly below its estimated fair value and maintains high insider ownership without recent substantial insider trading activity.
Take a closer look at Advanced Nano Products' potential here in our earnings growth report.
Our comprehensive valuation report raises the possibility that Advanced Nano Products is priced higher than what may be justified by its financials.
KOSDAQ:A121600 Ownership Breakdown as at Dec 2024
LifeTech Scientific (SEHK:1302)
Simply Wall St Growth Rating: ★★★★★☆
Overview: LifeTech Scientific Corporation is an investment holding company that develops, manufactures, and trades interventional medical devices for cardiovascular and peripheral vascular diseases globally, with a market cap of HK$7.08 billion.
Operations: The company's revenue segments include the Structural Heart Diseases Business at CN¥523.01 million, the Peripheral Vascular Diseases Business at CN¥725.13 million, and the Cardiac Pacing and Electrophysiology Business at CN¥32.36 million.
Insider Ownership: 16%
LifeTech Scientific is positioned for robust growth, with earnings projected to increase 29.5% annually, surpassing the Hong Kong market's 11.4%. Revenue is expected to grow at 21.5% per year, exceeding the market average of 7.8%. However, profit margins have decreased from last year's 28% to 19.4%, partly due to large one-off items affecting results. Despite these challenges, insider ownership remains high with no recent significant insider trading activity reported.
Click here to discover the nuances of LifeTech Scientific with our detailed analytical future growth report.
In light of our recent valuation report, it seems possible that LifeTech Scientific is trading beyond its estimated value.
SEHK:1302 Earnings and Revenue Growth as at Dec 2024
Zhejiang Jolly PharmaceuticalLTD (SZSE:300181)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Zhejiang Jolly Pharmaceutical Co., LTD is involved in the research, production, and marketing of Chinese medicinal products both domestically and internationally, with a market cap of CN¥11.66 billion.
Operations: The company generates revenue through its research, production, and marketing of Chinese medicinal products in both domestic and international markets.
Insider Ownership: 24%
Zhejiang Jolly Pharmaceutical shows promising growth potential, with earnings having increased by 45.4% over the past year and projected to grow 23.28% annually. Revenue is also expected to rise by 22.5% per year, outpacing the Chinese market's average growth rate. Recent earnings report highlights a net income of CNY 421.48 million for nine months ended September 2024, up from CNY 286.87 million last year, reflecting strong financial performance despite limited recent insider trading activity.
Dive into the specifics of Zhejiang Jolly PharmaceuticalLTD here with our thorough growth forecast report.
The valuation report we've compiled suggests that Zhejiang Jolly Pharmaceutica

Number: 1
URL: https://simplywall.st/stocks/us/healthcare/nasdaq-slp/simulations-plus/news/us-growth-stocks-with-high-insider-ownership-for-december-20
CONTENT: As the U.S. stock market pulls back from recent record highs, investors are closely watching economic indicators and Federal Reserve decisions for clues on future trends. In this environment of fluctuating indices and persistent inflationary pressures, growth companies with high insider ownership often attract attention due to their potential for aligned interests between management and shareholders.
Top 10 Growth Companies With High Insider Ownership In The United States
Name Insider Ownership Earnings Growth
Atour Lifestyle Holdings (NasdaqGS:ATAT) 26% 25.7%
Super Micro Computer (NasdaqGS:SMCI) 14.4% 24.3%
Duolingo (NasdaqGS:DUOL) 14.7% 34.7%
On Holding (NYSE:ONON) 19.1% 29.4%
Clene (NasdaqCM:CLNN) 21.6% 59.2%
EHang Holdings (NasdaqGM:EH) 32.8% 81.5%
Credo Technology Group Holding (NasdaqGS:CRDO) 13.5% 65.9%
BBB Foods (NYSE:TBBB) 22.9% 41.5%
Credit Acceptance (NasdaqGS:CACC) 14.0% 49%
Loop Industries (NasdaqGM:LOOP) 33% 63.5%

Click here to see the full list of 201 stocks from our Fast Growing US Companies With High Insider Ownership screener.
Let's take a closer look at a couple of our picks from the screened companies.
Simulations Plus (NasdaqGS:SLP)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Simulations Plus, Inc. develops software for drug discovery and development using AI and machine learning to model and simulate molecular properties, with a market cap of approximately $614.56 million.
Operations: The company's revenue is derived from two main segments: Services, contributing $28.99 million, and Software, which generates $41.02 million.
Insider Ownership: 18%
Simulations Plus, known for its high insider ownership, is poised for growth with revenue and earnings projected to outpace the US market. Recent developments include a grant from the FDA to enhance drug formulation technologies and a strategic focus on acquisitions to bolster organic growth. Despite trading below estimated fair value, the company reported stable financial results with FY2024 revenue at US$70.01 million and anticipates FY2025 revenue between US$90 million and US$93 million.
Dive into the specifics of Simulations Plus here with our thorough growth forecast report.
In light of our recent valuation report, it seems possible that Simulations Plus is trading beyond its estimated value.
NasdaqGS:SLP Ownership Breakdown as at Dec 2024
BRC (NYSE:BRCC)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: BRC Inc. operates in the United States, focusing on purchasing,